Analyzing Cancer Cells to Choose Treatments
Microfluidics chips allow scientists to study circulating cancer cells and determine their vulnerabilities. By Emily Singer from MIT Technology Review In a new clinical trial for prostate cancer, scientists will capture rare tumor cells circulating in patients’ blood, analyze them using a specialized microchip, and use the results to try to predict how well the patient will respond to a drug. The trial reflects a new phase of personalized medicine for cancer, enabled by microfluidics technologies that can isolate scarce cancer cells and detect very small changes in gene expression.
Analyzing Cancer Cells to Choose Treatments Read More »